Use of laptops and other technology in the classroom

…, JL Fink, N D'Antonio, G Russo-Alvarez - American Journal of …, 2010 - ajpe.org
To the Editor. I read the article ‘‘Why We Banned Use of Laptops and ‘Scribe Notes’ in Our
Classroom,’’1 and related many of the experiences shared by the author. As a faculty member …

Thromboembolic and major bleeding events with rivaroxaban versus warfarin use in a real-world setting

G Russo-Alvarez, KA Martinez… - Annals of …, 2018 - journals.sagepub.com
Background: Although randomized trials demonstrate the noninferiority of rivaroxaban
compared with warfarin in the context of nonvalvular atrial fibrillation (AF), little is known about …

[HTML][HTML] Predicting hypertension control using machine learning

…, M Griffin, R Cartabuke, L Laffin, G Russo-Alvarez… - Plos one, 2024 - journals.plos.org
Hypertension is a widely prevalent disease and uncontrolled hypertension predisposes affected
individuals to severe adverse effects. Though the importance of controlling hypertension …

Patient and physician factors contributing to polypharmacy among older patients

…, B Hu, LD Kim, S Lam, G Russo-Alvarez… - Current Medical …, 2022 - Taylor & Francis
Objective Polypharmacy, or use of multiple medications, is associated with patient factors.
Less is known regarding variation in polypharmacy by individual physicians. The objective of …

[PDF][PDF] Starting insulin in patients with type 2 diabetes: an individualized approach

A Brateanu, G Russo-Alvarez, C Nielsen - Cleve Clin J Med, 2015 - academia.edu
Because type 2 diabetes mellitus is a progressive disease, most patients eventually need
insulin. When and how to start insulin therapy are not one-size-fits-all decisions but rather must …

Endocrinology/Primary Care Pharmacy Collaboration vs Endocrinology Care Alone in Patients With Type 2 Diabetes and A1c> 9%

CR Fornwald, G Russo-Alvarez… - Journal of …, 2024 - journals.sagepub.com
Background: Type 2 diabetes (T2D) requires close collaboration between patients and their
care management team, often including endocrinology. Primary care pharmacist impact on …

Development of an ambulatory clinical pharmacy prioritization prediction model for patients with diabetes

SW Lam, G Russo-Alvarez, C Cristiani… - Annals of …, 2017 - journals.sagepub.com
Background: Health care reform and the projected shortage of primary care physicians
necessitate more efficient use of multidisciplinary collaboration. No studies, to date, have …

[HTML][HTML] Prevalence of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitor Prescribing in Patients with Type 2 Diabetes Mellitus and Reduced Estimated Glomerular …

K Chonko, G Russo-Alvarez, D Isaacs… - Innovations in …, 2023 - ncbi.nlm.nih.gov
Sodium glucose cotransporter 2 (SGLT-2) inhibitors have demonstrated benefit in people with
type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), including slowing the …

Evaluation of pharmacist impact on diabetes outcomes for telehealth and hybrid care delivery versus in-office visits

…, J Hockings, T Hermiller, G Russo-Alvarez… - Journal of the American …, 2023 - Elsevier
Background Few studies have examined the effect of pharmacist-led telemanagement on
diabetes outcomes during the COVID-19 pandemic. Objectives Assess for noninferiority for the …

Hospital admission rates of patients enrolled in pharmacist vs nurse anticoagulation management services

N Tarasiuk, M Parker, G RussoAlvarez… - Journal of the …, 2018 - Wiley Online Library
Introduction Various health care professionals provide dedicated anticoagulation management
services (AMS). There is limited literature describing head‐to‐head trials comparing …